Instrument Business Outlook Volume 29 - Issue 19
15 Jan 2021
Categories:
Instrument Business Outlook
Table of Contents
- The IBO 2021 Industry Forecast
- Life Science: Double-Digit Growth Ahead
- Mass Spectrometry: Industrial Markets to Improve
- Chromatography: Growth to Bounce Back
- Laboratory Automation: COVID-19 Testing Stokes Demand
- Surface Science: Electron and Super-Resolution Microscopy Sustain Growth
- Molecular Spectroscopy: Pent-up Demand to Fuel Growth
- Atomic Spectroscopy: Poised for a Come Back
- Materials Characterization: Life Science to Lead Increases
- Sample Preparation: Nucleic Acid Prep to Continue to Benefit from COVID-19 Testing
- Laboratory Equipment: Steady Climb Led by Select Technologies
- End-Market Forecast: Pharma and Biotech Strong but Academia Slow to Improve
- Regional Forecast: North America and Europe Lag Behind
-
2020 Developments and Trends
- COVID Hit and Miss
- IPO Frenzy
- Biopharma Stays Strong
- Aftermarket Take Share
- Cell Analysis Boom
-
Executive Briefing
- Carlyle Invests in X-ray Spectroscopy
- Teledyne to Purchase FLIR for $8 Billion
- PerkinElmer Enters into $500 Million Deal for TB Testing Company
- Sartorius Makes Further Chromatography Investments
- Environment Testing Chamber and Incubator Firm Gains New Investment
- Chromatography Firm Contemplates Acquisitions
- Neogen Buys Food Lab Supplier
- BGI Charges Illumina with Antitrust and Unfair Competition Allegations
- Gamma Biosciences Makes Third Acquisition in Five Months
- Laboratory Tool Companies’ Preliminary Results Show Ongoing Sales Recovery
- Bottom Line